Mauna Kea: share price falls after cash flow update

(CercleFinance.com) - On Tuesday evening, Mauna Kea Technologies confirmed its objective of achieving sales growth in excess of 20% by 2024.


In the third quarter of 2024, the medical imaging specialist reported sales, excluding license revenues, of 1.2 million euros, up 24% thanks to higher system sales.

The specialist in miniprobe and needle-based laser endomicroscopy also confirmed its break-even trajectory, with a 9% reduction in operating expenses.

But its net loss for the first six months of the year stood at 4.7 million euros, a sharp increase on the first half of 2023, which had benefited from non-recurring income of 7.7 million euros.

At the end of June, its cash position stood at 3.8 million euros, offering financial visibility until the end of the first quarter of 2025, leading the company to actively seek new financing solutions in order to extend its financial visibility.

Following this publication, the share price fell by more than 8% on the Paris Bourse at mid-day Wednesday.

Copyright (c) 2024 CercleFinance.com. All rights reserved.